Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib
暂无分享，去创建一个
Justin K. Huang | P. Mandal | Jason P. Burke | F. Mseeh | C. Bristow | S. Seth | E. Suzuki | T. Heffernan | G. Draetta | N. Kohl | Ningping Feng | P. Leonard | Philip Jones | M. Peoples | J. Marszalek | M. D. Di Francesco | Q. Chang | V. Ramamoorthy | N. Spencer | Jeffrey J Kovacs | J. Cross | Christopher C. Williams | A. Harris | Xiaoyan Ma | V. Giuliani | Qi Wu | G. Gao | Yuting Sun | Yongying Jiang | Meredith A. Miller | Zhijun Kang | C. Carroll | Sarah B. Johnson | Caroline C. Carrillo | Timothy J. McAfoos | B. Czako | Connor A. Parker | Simon S. Yu | B. Bivona | R. Mullinax | B. A. Meyers | S. Gera | Chiu-Yi Liu | Anastasia M Lopez | Andy M. Zuniga | A. M. Lopez | B. Meyers | A. Lopez | Robert A. Mullinax | M. Di Francesco